Maximus Q3 Revenue Misses, Guidance Cut on Contract Change
MMS sits 18% above its 52-week low of $52.73.
Summary
Maximus reported a 5% revenue decline to $1.28B, missing the $1.33B consensus, driven by lower disaster and clinical volumes in U.S. Federal Services. Adjusted EPS of $2.22 edged past estimates, but the company lowered its FY26 adjusted EPS outlook to $7.90-$8.20 from prior expectations, citing a temporary contract change. Full-year revenue guidance was reiterated at $5.2B-$5.35B, though management expects results near the low end. The stock, which closed at $63.15, faces pressure from the guidance cut and top-line miss, despite ongoing buybacks and efficiency gains. This follows a Q2 beat and raised guidance in May, making the downward revision a notable shift in tone.
At the time of this announcement, MMS was trading at $62.04 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $52.73 to $100.00. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.